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Abstract
Purpose MicroRNAs (miRNAs) are small non-coding
RNA molecules that play critical roles in post-transcrip-
tional gene expression regulation. The aim of this study
was to identify differentially expressed miRNAs in decidua
and villus of recurrent miscarriage (RM) patients.
Methods Participants were recruited at the outpatient
Department of Gynecology and Obstetrics, The Second
Hospital of Tianjin Medical University, China. Decidua
and villus tissues were collected by curettage from
recruited RM patients and normal pregnant women with
their informed consent. MiRNAs expression profiles in
decidua or villus were respectively determined by the deep-
sequencing analysis. The predicated target genes of these
differentially expressed miRNAs were analyzed by miR-
Walk. The differential expressions of four miRNAs in
decidua and four miRNAs in villus between the six pairs of
RM patients and normal pregnant women were confirmed
by qRT-PCR analysis. The expression patterns of two
predicated target genes, Bcl-2 and Pten, in the same six
pairs of decidual or villus tissues were detected by Western
blotting analysis, respectively.
Results Totally 18 RM patients and 15 normal pregnant
women were recruited. Thirty-two miRNAs in decidua and
four miRNAs in villus of RM patients were screened out to
be significantly up-regulated compared to that of normal
pregnant women, and five miRNAs in villus of RM patients
were screened out to be remarkably down-regulated com-
pared to that of normal pregnant women (P value\ 0.05
and Fold change[2). These differentially expressed
miRNAs were predicted to target a large number of genes
that involved in cell apoptosis, p53 signaling pathway, cell
cycle and other cellular bio-functions. Differential
expressions of hsa-miR-516a-5p, -517a-3p, -519a-3p and -
519d in decidua, as well as hsa-miR-1, -372, -100-5p and -
146a-5p in villus, were validated by qRT-PCR analysis. In
the decidual of RM patients, expression of hsa-miR-516a-
5p, -517a-3p, -519a-3p and -519d were significantly up-
regulated compared to normal pregnancy. In the villi of
RM patients, expression of hsa-miR-100 and -146a-5p
were significantly higher, while hsa-miR-1 and -372 were
significantly lower compared to normal pregnancy. Fur-
thermore, the expression of Bcl-2 and Pten, a predicated
target gene of hsa-miR-1 or hsa-miR-372 respectively, was
significantly up-regulated in the villi of RM patients.
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Conclusions These data suggested that the pathogenic
process of RM might be associated with the alteration of
miRNAs expression profiles in decidua and villus. Espe-
cially, the aberrant placental expression of hsa-miR-1 and -
372 might be involved in the progression of RM, but need
to be further investigated by larger studies in the future.
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Recurrent miscarriage (RM) has been defined as two or
more consecutive pregnancy losses prior to the 20th week
of gestation in human, and occurs in 1–2 % of pregnant
women at reproductive age [1, 2], and the etiology of 68 %
RM cases are unexplained [3]. Although the female causes
of RM have been attributed to uterine structural defects,
abnormal development of embryo, defective immunologi-
cally regulation at the maternal-fetal interface and free
radical metabolism imbalance [4], the exact pathogenic
mechanisms underlying RM remain unclear.
MicroRNAs (miRNAs), as a class of small non-coding
RNA molecules of 21–24 nucleotides, are widely expres-
sed in mammals to participate in post-transcriptional reg-
ulation of gene expression [5]. Mature miRNAs are
incorporated into the RNA inducing silencing complex,
and target-specific messenger RNAs via imperfect base
pairing for translational repression or mRNA cleavage [6].
It has been estimated that miRNAs account for *1 % of
predicted genes in higher eukaryotic genomes, and 30 % of
functional genes are potential targets of miRNAs [7].
Therefore, miRNAs are believed to play pivotal roles in
many biological processes, including cell proliferation,
differentiation and apoptosis [8]. Most miRNAs are con-
served between different species, and approximately 30 %
of miRNAs sequences are highly conserved between ver-
tebrate and invertebrate genomes [9]. In particular, as they
are stable and detectable in peripheral blood, miRNAs are
emerging as biomarkers for clinical screening or diagnosis
of human diseases [10].
In recent years, accumulating evidences indicate that
abnormal expression of miRNAs is associated with multi-
ple human reproductive disorders including endometriosis,
preeclampsia, ectopic pregnancy and RM [11–13]. How-
ever, as more than 50,000 miRNAs are predicted to be
presented in a mammalian cell [14, 15], and one miRNA
could target multiple genes while one gene could be tar-
geted by several miRNAs, the network of miRNAs regu-
lation of gene expression is clearly complex and
sophisticated. Therefore, it is still necessary to screen and
identify specific miRNAs that are involved in the patho-
genic mechanisms of RM.
Recently, the deep-sequencing analysis, a high-
throughput transcriptomic approach, has been developed
and successfully applied to screening differentially
expressed miRNAs [16, 17]. Thus,the present study was
undertaken to screen differentially expressed miRNAs in
placental decidual or villi of RM patients by deep-se-
quencing analysis, with a view to provide new cues for the
future studies on pathogenic mechanisms of RM, and to
search for biomarker candidates that could be potentially




All participants in this study were recruited from June 2013
to August 2013 at the outpatient department of Gynecology
and Obstetrics, The Second Hospital of Tianjin Medical
University, China. Trying to avoid the disturbance of
confounding factors on subsequent analyses, all partici-
pants were recruited according to the same inclusion and
exclusion criteria. Eighteen RM patients [age
29.61 ± 4.41 years and gestational age at sampling
8.33 ± 1.80 weeks (mean ± SD)], who had experienced at
least two consecutive embryonic losses before the 12th
gestational week and whose current pregnancy loss was
objectively confirmed by transvaginal ultrasound exam,
were recruited in the RM group. All clinical summaries
about their personal history for thromboembolic disease
and successful pregnancy or previous pregnancy losses
were obtained. Classical risk factors such as abnormal
parental karyotypes, uterine anatomical abnormalities,
infectious diseases, luteal phase defects, diabetes mellitus,
thyroid dysfunction and hyperprolactinemia were excluded
by medical examinations. Meanwhile, 15 clinically normal
pregnant women [age 29.33 ± 6.94 years and gestational
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age at sampling 7.33 ± 0.82 weeks (mean ± SD)], which
were terminated for non-medical reasons and undergoing
legal abortions around the 6–12th gestational week were
recruited in the normal pregnancy group as the control.
They were also checked for classical risk factor for preg-
nancy loss. After informed consent was obtained, decidua
and villus tissues were collected by curettage from these 33
participants respectively. All the collected tissues were
immediately minced into small fragments and stored in
RNAlater tissue collection solution (Invitrogen, Carlsbad,
CA) at -80 C until further analyses in May 2014, namely,
these tissues have been stored for 9–11 months. This study
was approved by the Medical Ethics Committees of
Shanghai Institute of Planned Parenthood Research (Ref #
2013-7, 2013-12). Written informed consents were
obtained from all patients who provided tissue samples,
and we have also obtained consents to publish research
data derived from these collected samples.
Small RNA deep-sequencing and data analyses
The total RNA used for deep sequencing was extracted
from decidua and villus tissues using TRIzol reagent
according to the manufacturer’s protocol (Invitrogen),
respectively. The concentration of the total RNA product
was measured by NanoDrop (Thermo Scientific, Wilm-
ington, DE, USA), and the RNA integrity was checked on
Bioanalyzer2100 (Agilent, Santa Clara, CA). Two hundred
nanograms (200 ng) total RNA product of each case was
used for preparing small RNA libraries according to the
manufacturer’s instructions (Illumina, San Diego, CA), and
RNase inhibitor (Invitrogen) was contained in the reverse
transcription system. The cDNA libraries were sequenced
on Illumina HiSeq 2000 instrument with 50-base pair sin-
gle reads. Raw sequencing data was mapped to human
miRNAs database (miRBase v21) using Bowtie2. Then, a
Mann–Whitney test was performed to discover differen-
tially expressed miRNAs between RM group and normal
pregnancy group. These miRNAs with P value\0.05 and
Fold change[2 were judged being significantly differen-
tially expressed in the decidua or villus of RM patients
compared to normal pregnant women. The predicted target
mRNAs of these differentially expressed miRNAs were
predicted by miRWalk (http://www.umm.uni-hei
delbergde/apps/zmf/mirwalk/mirnatargetpub.html).
Quantitative RT-PCR
Total RNA samples of decidua and villus tissues were
extracted using TRIzol according to the manufacturer’s
instructions (Invitrogen) respectively, and quantified using the
NanoDrop ND-1000 (Thermo Scientific). Single-stranded
cDNA was synthesized using a reverse transcription kit
system (Applied Biosystems, Foster City, CA, USA). Real-
time PCR was carried out using FastStart Universal SYBR
Green Master (Roche Diagnostics, Welwyn Garden City,
UK) and analysed using an ABI 7900 HT (Applied Biosys-
tems). All miRNAs Assay primers used in this study were
purchased commercially (RiboBio, Guangzhou, Guangdong
Province, China). Primer efficiencies were determined by
standard curve. Relative miRNAs expression was calculated
by efficiency-corrected DDCt method, normalized to the
endogenous control U6 snRNA. Each sample in RM group
and normal pregnancy group was measured in triplicate and
the experiment was repeated for at least three times.
Western blotting
The collected decidua and villus tissues were quickly frozen
in liquid nitrogen, and granulated into fine powder. The tissue
powder was homogenized in lysis buffer (Beyotime, China).
The tissue lysate was centrifuged, and the supernatant was
transferred into a new tube. Protein concentration was mea-
sured by the Bradford assay (Bio-Rad, Hercules, CA). Protein
concentrations were determined using a standard Bradford
assay, and 50 lg of total protein was separated on a 12 %
acrylamide gel, and then transferred electrophoretically onto
nitrocellulose membranes (Millipore, Darmstadt, Germany).
Membranes were incubated overnight at 4 C with specific
primary antibodies against Bcl-2, Pten and b-actin (Santa
Cruz, Santa Cruz, CA), followed by incubation with appro-
priate secondary antibody. The blot was developed using the
PhosphaGLO AP Substrate kit (KPL, Gaithersburg, MD)
according to the manufacturer’s protocol. Samples were
subjected to Western blotting analysis, which was repeated in
triplicates. To ensure accurate comparability between exper-
iments, bands intensity was quantified by densitometry using
ImageJ software (US National Institutes of Health, Maryland,
USA) and normalized to internal control.
Statistical analysis
All values are presented as mean ± SEM. Statistical
comparisons among groups were analyzed by one-way
ANOVA followed by Student’s t test using SPSS software
package (version 19, SPSS Inc., Chicago, IL). A value of
P\ 0.05 was considered significant.
Results
Differentially expressed miRNAs in decidua
and villus of RM patients
Human decidua and villus tissues were obtained from 18
RM patients and 15 normal pregnant women. No
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significant differences were observed in the age and ges-
tational period between the two groups (Table 1). Total
RNA product was respectively extracted from each tissue
sample. After checking the RNA integrity, all of 18 RM
decidua RNA samples and 15 normal pregnancy decidua
RNA samples were qualified for subsequent analysis;
however, only three RM villus RNA samples (4, 10 and
12 V) and four normal pregnancy villus RNA samples (C2
V, C4 V, C7 V and C10 V) were qualified to construct
cDNA libraries for deep sequencing [RNA integrities
Table 1 Clinical characteristics of the recruited 18 RM patients and 15 normal pregnant women information about recruited 18 RM patients and
15 normal pregnancy women
Group Sample no Age Gestational weeks Childbearing history Spontaneous abortion history
RM 1 28 8 0 4
2 28 9 0 2
3 35 6 0 3
4 26 10 0 2
5 34 12 1 2
6 27 6 1 3
7 30 8 0 2
8 28 7 0 3
9 32 8 0 2
10 33 8 1 3
11 42 8 1 2
12 25 6 0 3
13 29 8 0 2
14 27 12 0 2
15 28 8 0 3
16 31 11 0 3
17 27 7 0 4
18 23 8 0 2
Mean ± SD P*
Age 29.61 ± 4.41 [0.05
Gestational weeks 8.33 ± 1.80 [0.05
Group Sample no Age Gestational weeks Childbearing history Medical abortion history
Normal pregnancy C1 31 7 1 2
C2 42 7 1 3
C3 26 8 0 1
C4 40 9 1 2
C5 31 6 1 2
C6 29 7 0 1
C7 27 7 1 2
C8 26 6 1 2
C9 19 7 0 2
C10 37 7 1 3
C11 37 8 1 3
C12 22 8 0 3
C13 27 7 0 1
C14 24 8 0 1
C15 22 8 0 1
Mean ± SD
Age 29.33 ± 6.94
Gestational weeks 7.33 ± 0.82
* Compared to that of normal pregnancy
1128 Arch Gynecol Obstet (2016) 293:1125–1135
123
(RIN) C 7 and 28 s/18 s C 0.7]. Differentially expressed
miRNAs were screened out by meeting our designated
criteria: P\ 0.05 and fold change[2. A total of 32
miRNAs were screened to be significantly up-regulated in
decidua of RM patients, whereas a total of nine miRNAs
was differentially expressed in villus of RM patients,
including four up-regulated and five down-regulated miR-
NAs (Fig. 1; Table 2). To validate the reliability of the
deep-sequencing data, we selected four miRNAs from
decidua (hsa-miR-516a-5p, 517a-3p, 519a-3p and 519d)
and four miRNAs from villus (hsa-miR-1, 372, 100-5p and
146a-5p) to confirm their differential expressions in
decidua or villus between RM and normal pregnancy group
by qRT-PCR analysis. As the villous RNA sample sizes
used for deep-sequencing were too small, another three RM
villous RNA samples (1, 2, 3 V,) and two normal preg-
nancy villous (C1 V and C8 V) RNA samples, whose
integrities were qualified for qRT-PCR analysis (RIN C 6
and 28 s/18 s C 0.7), were also chosen to be used in qRT-
PCR analysis. The qRT-PCR results showed that the
expression patterns of all eight selected miRNAs were in
concordance with the deep-sequencing data, indicating the
deep-sequencing data were reliable (Fig. 2).
Functional analysis of differentially expressed
miRNAs in RM patients
A total of 252 putative target mRNAs of 32 differentially
expressed miRNAs in decidua, as well as 1281 putative
target mRNAs of nine differentially expressed miRNAs in
villus were predicted by miRWalk. The functions of pre-
dicted target genes and molecular pathways they poten-
tially constitute were assessed using the Gene Ontology
(GO) and the Kyoto Encyclopedia of Genes and Genomes
(KEGG) analyses. In decidua of RM patients, the predicted
targets were significantly enriched for cell death, apoptosis,
Fig. 1 Expression profile of miRNAs in villus and decidua of RM
and normal pregnancy. a Heatmap of differentially expressed
miRNAs in decidua. b Log–log scatter plot comparing global
miRNAs expression profiles in decidua of RM patients with those
of normal pregnancy. c Heatmap of differentially expressed miRNAs
in villus. d Log–log scatter plot comparing global miRNAs expres-
sion profiles in villus of RM patients with those of normal pregnancy
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cell proliferation and response to hormone stimulus
(Fig. 3a), which known to be participated in decidual
development during embryo implantation. The pathway
analysis showed that the predicted targets gene were
involved in cancer, ErbB signaling pathway, focal adhesion
and p53 signaling pathway, etc. (Fig. 3b). In the villus of
RM patients, the predicted targets were significantly enri-
ched for several biological processes known to be involved
in embryonic or fetal development, such as cell prolifera-
tion, anti-apoptosis, blood vessel development (Fig. 3c).
The pathway analysis showed that the predicted genes in
villus were participated in apoptosis, p53-signaling path-
way, cell cycle, et al. (Fig. 3d).
Differential expressions of Bcl-2 and Pten proteins
in villus of RM patients
Given Bcl-2 mRNA was predicted as a target of miR-1, and
Pten mRNA was the predicted target of miR-372, the
expression levels of Bcl-2 and Pten proteins in villus of
RM patients and normal pregnant women were measured
by Western blot analysis. The results showed that, the
expression levels of Bcl-2 and Pten in villus of RM patients
were significantly increased compared to normal preg-
nancy women (P\ 0.05) (Fig. 4), in consistent with the
down-regulated expressions of miR-1 and -372 in villus of
RM patients.
Discussion
In this study, we observed the differentially miRNAs
expression profiles in villus and decidua of RM patients
compared to that of normal pregnant women by using deep
sequencing analysis. A total of 32 miRNAs were screened
out to be significantly up-regualted in decidua of RM
patients, while nine miRNAs were identified to be differ-
entially expressed in placental villi of RM patients,
including four up-regulated (hsa-miR-191-5p, -24-3p, -
100-5p and -146a-5p) and five down-regulated (hsa-miR-1,
-372, -371a-5p, -376c-3p and -486-5p) miRNAs, compared
to that of normal pregnant women. We further confirmed
by qRT-PCR the up-regulation of hsa-miR-516-5p, -517a-
3p, -519a-3p and -519d in decidua of RM patients, and hsa-
miR-100-5p and -146a-5p in villus of RM patients; as well
as the down-regulation of hsa-miR-1 and -372 in villus of
RM patients. Furthermore, the increased expressions of
Bcl-2, a predicted target of miR-1, and Pten, a predicted
target of miR-372 were observed in villus of RM patients.
Recurrent miscarriage is presently difficult to be pre-
vented and treated for the lack of knowledge on molecular
mechanisms of this disease. Thus, in order to identify novel
potential targets for the clinical diagnosis or treatment of
RM, we tried to establish the miRNAs expression profiles
in the decidua and villus from RM patients in this study.
Although we have successfully recruited 18 RM patients
and 15 normal pregnant women, and all of the 33 total
Table 2 List of 41 miRNAs found by deep-sequencing analysis to be
differentially expressed between RM and normal pregnancy
miRNA Fold change (vs control) q value Style
Differentially expressed miRNAs in decidua
hsa-miR-455-5p 2.19237434 0.04210158 Up
hsa-miR-934 4.18316511 0.00336399 Up
hsa-miR-525-5p 4.52186441 0.00003267 Up
hsa-miR-526b-5p 6.03780951 0.00000000 Up
hsa-miR-518c-3p 6.16948470 0.01993339 Up
hsa-miR-512-3p 6.17784129 0.00000000 Up
hsa-miR-1323 6.73950523 0.00000000 Up
hsa-miR-519d 8.10401668 0.00000000 Up
hsa-miR-516b-5p 8.66095224 0.00000000 Up
hsa-miR-520a-5p 9.03341830 0.00000000 Up
hsa-miR-205-5p 9.09559597 0.01232602 Up
hsa-miR-517c-3p 9.71527515 0.00000000 Up
hsa-miR-515-5p 9.83027638 0.00000000 Up
hsa-miR-523-5p 10.41084563 0.00000000 Up
hsa-miR-519b-3p 10.62396302 0.00537841 Up
hsa-miR-520a-3p 10.75501821 0.00000000 Up
hsa-miR-517a-3p 10.98821684 0.00000000 Up
hsa-miR-516a-5p 11.01941342 0.00000000 Up
hsa-miR-526a 11.10143967 0.00001016 Up
hsa-miR-520 g 12.65580255 0.00000000 Up
hsa-miR-498 14.76914649 0.00110414 Up
hsa-miR-519c-3p 14.91286942 0.00000420 Up
hsa-miR-520 h 15.48282744 0.01447064 Up
hsa-miR-524-5p 15.85564708 0.00000000 Up
hsa-miR-519e-5p 16.65645394 0.00050412 Up
hsa-miR-518e-3p 21.17422809 0.00000429 Up
hsa-miR-520d-5p 21.76428230 0.00000000 Up
hsa-miR-522-3p 21.79447724 0.00000000 Up
hsa-miR-518a-3p 25.10813623 0.00000461 Up
hsa-miR-519a-3p 27.41347031 0.00000000 Up
hsa-miR-521 28.85390185 0.00014809 Up
hsa-miR-1283 39.06915307 0.00000000 Up
Differentially expressed miRNAs in villi
hsa-miR-1 0.21733720 0.00088976 Down
hsa-miR-372 0.22803727 0.00205597 Down
hsa-miR-371a-5p 0.25742330 0.00304584 Down
hsa-miR-376c-3p 0.28742144 0.02509974 Down
hsa-miR-486-5p 0.30897628 0.03455981 Down
hsa-miR-191-5p 2.11589617 0.00726491 Up
hsa-miR-24-3p 2.89758058 0.00004947 Up
hsa-miR-100-5p 3.70431902 0.00000000 Up
hsa-miR-146a-5p 4.45436783 0.00088976 Up
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RNA samples from decidual tissues were qualified for
deep-sequencing analysis; however, unfortunately, only
three samples of villus total RNA in RM group and four
samples of villus total RNA in normal pregnancy group
met the requests on RNA integrity for construction of
cDNA libraries. We thought that this might be resulted
from a relatively long storage time of villous tissue samples
(more than 9 months), and it seems that, under the same
storage conditions, human decidua tissue samples should
be much more stable than villus tissue samples. The size of
villus samples was so small that we wonder whether or not
the results of the deep-sequencing analysis were reliable.
Six pairs of decidua and villus from RM patients and
normal pregnancy controls were used for validation of
eight selected miRNAs by qRT-PCR, and the results of
qPCR were extremely consistent with deep sequencing
data, indicating that the deep sequencing data were reliable.
Since each miRNA has been predicted to have a broad
range of target mRNAs based on the degree of sequence
homology, these 32 miRNAs in decidua and 9 miRNAs in
villus could undoubtedly be involved in different cellular
functions, and we wonder whether or not these cellular
functions would be important for establishment and
maintenance of pregnancy. The GO ananlysis provides a
comprehensive source for functional genomics, and is an
effective bioinformatics research tool to unify the repre-
sentation of gene and gene product, and creates evidence-
supported annotations to describe the biological roles of
individual genomic products (e.g. genes, proteins,
ncRNAs, complexes) [18]. Thus, we carried out the GO
analysis for the 1533 predicted target genes (252 in decidua
and 1281 in villus) of these differentially expressed miR-
NAs. It was revealed that, in decidua, these predicted target
genes are mainly participated in cell death, apoptosis, cell
proliferation and hormone stimulus, and the major KEGG
pathways were cancer, ErbB signaling, focal adhesion,
p53-signaling and apoptosis. Meanwhile, in villus, these
target genes are mostly involved in the regulation of cell
proliferation, apoptosis, blood vessel development and
angiogenesis; and the major KEGG pathways analysis were
apoptosis, p53-signaling and cell cycle. The pathologies
that lead to RM must ultimately, either directly or indi-
rectly, affect the interaction between the maternal
endometrial (decidual) and trophoblastic tissue [19].
According to the GO analysis results, the aberrant
expression of these target genes in villus might affect tro-
phoblast invasion and placentation, while aberrant
expression of these target genes in decidua could adversely
impact trophoblast invasion [20]. More interestingly, given
the p53-signaling pathway plays critical roles in apoptosis,
and an advisable apoptosis of decidual cells, trophoblast
cells and decidual immune cells are thought to be essential
for the establishment and maintenance of pregnancy [21,
22], we speculated that the differentially expressed miR-
NAs (such as hsa-miR-519a, hsa-miR-517a, hsa-miR-205,
hsa-miR-1, hsa-miR-372 and has-miR-486) which target
apoptosis related gene, might involved in the regulation of
p53-signaling and apoptosis might participate in the
pathogenesis of RM.
Bcl-2, a key regulator of cell apoptosis, was identified as
a predicted target of miR-1, a down-regulated miRNA in
villus of RM patients. MiR-1 is a member of the muscle-
specific miR-1 family (myomiRs) that currently consists of
six members [23]. It has previously been reported that,
miR-1 inhibits cell proliferation but promotes cell differ-
entiation, and is involved in tumorigenesis as a tumor
suppressor. Its expression is abnormally down-regulated in
several types of cancers, including lung, prostate, col-
orectal cancers and rhabdomyosarcoma [24]. The abnor-
malities of Bcl-2 function have been implicated in many
diseases including cancer, neurodegenerative disorders and
autoimmune diseases [25]. It was observed in this study
that, the expression level of Bcl-2 protein was significantly
increased in RM villus, suggesting an inhibitory effect of
Fig. 2 Comparison of
expression levels of selected
miRNAs between RM patients
and normal pregnant controls.
a Decidua. b Villus.
*Significantly different from
control (P\ 0.05) (n = 6). RM
recurrent miscarriage
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Fig. 3 Functional analyses of
differentially expressed
miRNA-predicted targets in
decidua and villus. a/c Results
of the GO analysis of the target
genes predicted by differentially
expressed miRNAs in deciduas
(a) and villus (c). b/d Main
biological processes of genes
targeted by differentially
expressed miRNAs in deciduas
(b) and villus (d)
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miR-1 on Bcl-2, and the miR-1/Bcl-2 signaling might be
involved in the progression of RM. We also noticed that,
two out of six bands of Bcl-2 were higher expressed in
normal pregnancy than in RM, this might be resulted from
the individual differences or/and the gestational week
variation. As the cell proliferation and death of trophoblast
are active during the early placental development [26], the
heterogeneity of Bcl-2 expression might be observed in
different human villus tissues, calling for the validation by
a larger sample size. Meanwhile, it is confusing that, the
expression level of Bcl-2 in trophoblast cells increased
during placenta development [27], and a reduced expres-
sion of Bcl-2 was in association with pregnancy loss [28].
This may be due to the multiple and complex effects of
differentially expressed miRNAs on the microenvironment
of decidua and villus of RM patients. In order to improve
the clinical management of RM patients, great efforts have
been made to search for biomarkers potentially could be
used to predict adverse outcome of pregnancy at the early
stage, and miRNAs present promising biomarker candi-
dates of RM because the serum concentration of miRNA
could be measured in maternal peripheral blood samples [1,
29]. MiR-1 has been identified as potential diagnostic
biomarker for colorectal cancer [30]. Thus, the serum
concentrations of miR-1 in RM patients should be mea-
sured and compared with normal pregnant women to
explore the possibility of their acting as biomarker candi-
date for RM.
Pten, another important factor involved in p53-signaling
pathway and apoptosis, was predicted as a target gene of
miR-372, which was down-regulated in villus of RM
patients. MiR-372 belongs to the mir-371-372 gene cluster,
which is located on chromosome 19q13.42 [31]. Although
the role of miR-372 itself in reproductive regulation has not
been clear, it has been reported that, the expression level of
miRNA-371 was increased from first trimester trophoblast
cells to term trophoblast cells [32]. Further evidence rein-
forced that miR-371 cluster was up-regulated in the first
trimester placentas compared to the third trimester placentas,
indicating that miR-371 might play critical roles in placental
development [33]. Meanwhile, it has been demonstrated that
miR-372 regulated the cell cycle, apoptosis, invasion and
proliferation in several types of human cancers [34], thus, it
would be reasonable for us to speculate that miR-372 might
also be involved in placental development. To study the
correlation of miR-372 and Pten, we detected the expression
of Pten in villus of RM patients, and found that the
expression level of Pten was increased in RM villus, sug-
gesting an inhibitory effect of miR-372 on Pten, and the
miR-372/Pten signaling might be involved in the progres-
sion of RM. Consistently, it has been reported that, the
villous expression of Pten was decreased as the pregnancy
advanced, and an up-regulated expression of Pten was
observed in early pregnancy loss [35, 36]. It has been shown
that circulating serum mir-372 could serve as testicular germ
cell cancer biomarker [37]. So, miR-372 presents the
another biomarker candidate for RM that is needed to be
validated in larger size studies in the future.
In this study, we have screened out a number of
intriguing miRNAs expression differences between RM
Fig. 4 Western blot analysis of Bcl-2 and Pten expression in villus of
RM and normal pregnancy. Upper panel representative immunoblot
of three independent experiments. Lower panel quantification of
protein levels normalized to actin. Data are the mean ± SEM of three
experiments. * Significantly different (P\ 0.05) (n = 6)
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and normal pregnancy. To further authenticate the asso-
ciation between these differentially expressed miRNAs
and the pathologic process of RM, a case–control cohort
of RM with a considerably large size (at least 100 pairs)
should be established to collect the tissue and peripheral
blood samples. The aberrant expressions of miRNAs
might be linked to the abnormal cellular processes in RM
patients, but the hypotheses about the roles of each
specific miRNA in the progression of RM are needed to
be further investigated. Also, pregnancy complications are
notoriously hard to study in the laboratory because of the
absence of appropriate models of human pregnancy.
Furthermore, we found many changes in miRNAs
expression potentially affecting many different processes,
and it should to be note that, as the miscarried embryos
were dead, necrosis or inflammation might have occurred
in the dead embryonic tissues, whereas the embryonic
tissue of induced abortion was fresh, therefore the dif-
ferentially expressed miRNAs identified here might be the
result of miscarriage but not the causes.
Conclusions
Collectively, a number of miRNAs were identified to be
differentially expressed in decidua or villus tissues of
RM patients, and these miRNAs might be involved in
many bio-functions including p53-signaling and cell
apoptosis. The aberrant placental expression of hsa-miR-
1 and -372 might be involved in the progression of RM
by targeting Bcl-2 or Pten respectively. Future studies
will investigate the pathogenic roles of miR-1/Bcl-2 and
miR-372/Pten pathways in RM, as well as the associa-
tion of serum concentrations of miR-1, -372 and other
differentially expressed miRNAs with the pathogenic
process of RM.
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